Skip to content
MedsAcross

Medicine

Celecoxib 200 mg capsule

Celecoxib · Oral
Available on requestPrescription onlyUS FDAGeneric name

Celecoxib 200 mg capsule is a generic prescription medicine for oral use, made by 53 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted…

Key facts

Active ingredient (INN)
Celecoxib
Brand
Sold under the generic name
Strength
200 mg
Dosage form
Capsule
Route
Oral
Packs
80 capsules, 30 capsules, 100 capsules and 337 more
Manufacturers
Alembic PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaMicro LabsIndiaCadila PharmaceuticalsIndiaCiplaIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaAvet PharmaceuticalsIndiaLupinIndia53 labelers on the register
Origin register
US FDA, United States
Storage
Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01XX33 Celecoxib
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 March 2015
Identifiers
RxCUI 205322, 205323, 349514 +1DailyMed set ID 77f3b90b-a25d-4c47-975a-2a988d696a3f, 933532fa-044a-48b1-bbe4-28062564f98a, 0e8484a8-04a6-4be3-8c5c-1883b0490d53 +37NDC 85534-0015, 27808-297, 29300-373 +37Application ANDA205129, ANDA210071, ANDA213301 +14

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 53 labelers. The register lists 340 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
80 capsule in 1 carton46708-269-12Alembic PharmaceuticalsIndia22 August 2015
30 capsule in 1 bottle46708-269-30Alembic PharmaceuticalsIndia22 August 2015
100 capsule in 1 bottle46708-269-31Alembic PharmaceuticalsIndia22 August 2015
60 capsule in 1 bottle46708-269-60Alembic PharmaceuticalsIndia22 August 2015
500 capsule in 1 bottle46708-269-71Alembic PharmaceuticalsIndia22 August 2015
1000 capsule in 1 bottle46708-269-91Alembic PharmaceuticalsIndia22 August 2015
80 capsule in 1 carton62332-142-08Alembic PharmaceuticalsIndia1 December 2015
30 capsule in 1 bottle62332-142-30Alembic PharmaceuticalsIndia1 December 2015
100 capsule in 1 bottle62332-142-31Alembic PharmaceuticalsIndia1 December 2015
60 capsule in 1 bottle62332-142-60Alembic PharmaceuticalsIndia1 December 2015
500 capsule in 1 bottle62332-142-71Alembic PharmaceuticalsIndia1 December 2015
1000 capsule in 1 bottle62332-142-91Alembic PharmaceuticalsIndia1 December 2015
100 capsule in 1 bottle65862-909-01Aurobindo PharmaIndia1 February 2016
500 capsule in 1 bottle65862-909-05Aurobindo PharmaIndia1 February 2016
1000 capsule in 1 bottle65862-909-99Aurobindo PharmaIndia1 February 2016
100 capsule in 1 bottle23155-965-01Avet PharmaceuticalsIndia25 March 2026
500 capsule in 1 bottle23155-965-05Avet PharmaceuticalsIndia25 March 2026
60 capsule in 1 bottle71209-056-03Cadila PharmaceuticalsIndia23 August 2018
100 capsule in 1 bottle71209-056-05Cadila PharmaceuticalsIndia10 September 2021
500 capsule in 1 bottle71209-056-10Cadila PharmaceuticalsIndia10 September 2021
1000 capsule in 1 bottle71209-056-11Cadila PharmaceuticalsIndia23 August 2018
30 capsule in 1 bottle69097-421-02CiplaIndia23 September 2015
100 capsule in 1 bottle69097-421-07CiplaIndia23 September 2015
500 capsule in 1 bottle69097-421-12CiplaIndia23 September 2015
10 blister pack in 1 carton / 10 capsule in 1 blister pack69097-421-21CiplaIndia23 September 2015
100 capsule in 1 bottle68180-399-01LupinIndia9 December 2019
100 capsule in 1 bottle33342-157-11Macleods PharmaceuticalsIndia16 March 2016
10 blister pack in 1 carton / 10 capsule in 1 blister pack33342-157-12Macleods PharmaceuticalsIndia16 March 2016
500 capsule in 1 bottle33342-157-15Macleods PharmaceuticalsIndia16 March 2016
100 capsule in 1 bottle42571-144-01Micro LabsIndia1 June 2018
500 capsule in 1 bottle42571-144-05Micro LabsIndia1 June 2018
6 blister pack in 1 carton / 10 capsule in 1 blister pack42571-144-29Micro LabsIndia1 June 2018
30 capsule in 1 bottle42571-144-30Micro LabsIndia1 June 2018
60 capsule in 1 bottle42571-144-60Micro LabsIndia1 June 2018
100 capsule in 1 bottle13668-442-01Torrent PharmaceuticalsIndia23 December 2015
500 capsule in 1 bottle13668-442-05Torrent PharmaceuticalsIndia23 December 2015
1000 capsule in 1 bottle13668-442-10Torrent PharmaceuticalsIndia23 December 2015
30 capsule in 1 bottle13668-442-30Torrent PharmaceuticalsIndia23 December 2015
60 capsule in 1 bottle13668-442-60Torrent PharmaceuticalsIndia23 December 2015
90 capsule in 1 bottle13668-442-90Torrent PharmaceuticalsIndia23 December 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1998Drugs@FDA
EU (EMA)WithdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Celecoxib 200 mg capsule.

Compare 1

Other strengths and forms of Celecoxib

Clinical summary

Celecoxib is a nonsteroidal anti-inflammatory drug indicated cELEBREX is a nonsteroidal anti-inflammatory drug indicated for osteoarthritis (OA), among other approved uses. It is available as capsules, oral liquid and oral suspension. MedsAcross supplies Celecoxib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Celecoxib

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Celecoxib 200 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.